Table 1 Patient and treatment characteristics
Factors | Number (n = 21) | ||
|---|---|---|---|
Sex | Male | 17 | |
Female | 4 | ||
Age (years) | Median (range) | 68 (52–88) | |
Location (lobe)a | Right upper | 5 | |
Right middle | 3 | ||
Right lower | 4 | ||
Left upper | 6 | ||
Left lower | 7 | ||
T stage | 1 | 13 | |
2 | 5 | ||
3 | 3 | ||
N stage | 1 | 4 | |
2 | 8 | ||
3 | 9 | ||
Clinical stage | IIA | 4 | |
IIIA | 8 | ||
IIIB | 9 | ||
ECOG performance status | 0 | 2 | |
1 | 16 | ||
2 | 3 | ||
Weight loss | No | 18 | |
Yes | 3 | ||
Smoking history | No | 4 | |
Yes | 17 | ||
FEV1 (%) | Median (range) | 83 (51–116) | |
DLco (%)b | Median (range) | 73 (37–99) | |
Pathology | Squamous | 8 | |
Adenocarcinoma | 9 | ||
Unknown NSCLC | 1 | ||
SCLC | 3 | ||
Aim | Definitive | 15 | |
Salvage | 6 | ||
Radiotherapy dose (Gy) | SBRT | Median (range) | 54 (40–60) |
CRT | Median (range) | 60 (46–66) | |
Dose per fraction (Gy) | SBRT | Median (range) | 14 (10–15) |
CRT | Median (range) | 2 (2–6) | |
GTV (cc) | SBRT | Median (range) | 6.4 (1.2–29.2) |
CRT | Median (range) | 14.4 (0.9–104.8) | |
PTV (cc) | SBRT | Median (range) | 27.7 (8.2–89.6) |
CRT | Median (range) | 144.8 (27.7–404.1) | |
Chemotherapy | None | 9 | |
Neoadjuvant | 5 | ||
Concurrent | 4 | ||
Both | 3 | ||